Welcome to LookChem.com Sign In|Join Free

CAS

  • or

918943-29-0

Post Buying Request

918943-29-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

918943-29-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 918943-29-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,9,4 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 918943-29:
(8*9)+(7*1)+(6*8)+(5*9)+(4*4)+(3*3)+(2*2)+(1*9)=210
210 % 10 = 0
So 918943-29-0 is a valid CAS Registry Number.

918943-29-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(4-nitrophenyl)-1,3-benzoxazole-7-carboxylate

1.2 Other means of identification

Product number -
Other names 7-Benzoxazolecarboxylic acid,2-(4-nitrophenyl)-,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:918943-29-0 SDS

918943-29-0Downstream Products

918943-29-0Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS AHR MODULATORS

-

Page/Page column 14; 18; 19; 20; 26; 27; 28, (2020/03/24)

The present invention relates compounds of the general formula (I) or (III) which are ARH inhibitors, methods for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds and pharmaceutical compositions for the treatment or prevention of diseases, in particular cancer or conditions with dysregulated immune functions, or other conditions associated with aberrant AHR signalling, as a sole agent of in combination with other active ingredients. Such compounds may also be of utility in the expansion of hematopoietic stem cells (HSCs) and the use of HSCs in autologous or allogenic transplantation for the treatment of patients with inherited immunological and autoimmune diseases and diverse hematopoietic disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 918943-29-0